Although high FANCD2 expression levels in breast tumors have previously been linked to poor survival of the patients35, and one common FANCD2 SNP has been associated with sporadic breast cancer risk36, to our knowledge, this study is the first one reporting FANCD2 mutations in the context of familial breast cancer. This evidence concerns the gene FANCD2 and breast cancer.